Melissa Krauth heads up life science/biotech investments at 2M Companies, a Dallas-based family office. She leads a team to source and manage investments in companies seeking to make a significant impact on human health. Previously, Melissa was a senior executive with Reata Pharmaceuticals, where she oversaw company and product-level strategies and operations. During her tenure, the company grew from seven to 200 employees, and from a nominal to a multi-billion dollar valuation. Melissa also spent many as a strategy consultant serving executives at top pharmaceutical and biotech companies. She is an honors graduate from Rice University with a BA in biochemistry and earned an MBA in health care management and strategic management from the Wharton School of the University of Pennsylvania.